Despite assurances from President Donald Trump’s administration in January that the coronavirus outbreak in the country is under control, new COVID cases in the country continued to rise. In fact, the U.S. is now the leading country in terms of the number of confirmed infections after surpassing China and Italy last week.
The recent development did not escape Hillary Clinton who has been consistently critical of President Donald Trump’s handling of the coronavirus pandemic. On Friday, the former Secretary of State took to Twitter mocking her former campaign rival and linking his “America First” slogan to the current top spot the U.S. occupies in terms of COVID-19 cases, according to Newsweek.
“He did promise ‘America First,’” Clinton tweeted. She also shared a New York Times article that reported how the U.S. became the country hardest hit by the coronavirus pandemic on Thursday.
There are now more than 150 thousand people confirmed to be infected with the virus in the U.S. There are now more than 2,800 reported deaths due to the virus.
Trump used the “America First” slogan during his 2016 campaign against Clinton. “We assembled here today are issuing a new decree to be heard in every city, in every foreign capital, and in every hall of power,” Trump said in his January 2017 inaugural address. “From this day forward, a new vision will govern our land. From this moment on, it's going to be America First.”
Clinton also criticized Trump for contradicting medical experts. “A month ago, Trump said: ‘It’s going to disappear. One day, it’s like a miracle, it will disappear,’” she wrote on a different post. “Yesterday, he said: ‘I don’t believe you need 40,000 or 30,000 ventilators.’ What will it take to get @realdonaldtrump to listen to experts instead of his own hunches?”
The former Secretary of State also criticized Trump’s response to the pandemic. “The Trump administration was told in January that coronavirus was likely to become a pandemic,” she wrote in a tweet last week. “They refused to act for fear of spooking the markets, losing weeks of time to prepare that we won't get back.”


Sanofi Gains China Approval for Myqorzo and Redemplo, Strengthening Rare Disease Portfolio
U.S. Lawmakers to Review Unredacted Jeffrey Epstein DOJ Files Starting Monday
Ohio Man Indicted for Alleged Threat Against Vice President JD Vance, Faces Additional Federal Charges
TrumpRx.gov Highlights GLP-1 Drug Discounts but Offers Limited Savings for Most Americans
Novo Nordisk Stock Surges After FDA Approves Wegovy Pill for Weight Loss
Royalty Pharma Stock Rises After Acquiring Full Evrysdi Royalty Rights from PTC Therapeutics
Nicaragua Ends Visa-Free Entry for Cubans, Disrupting Key Migration Route to the U.S.
Trump Lifts 25% Tariff on Indian Goods in Strategic U.S.–India Trade and Energy Deal
Trump’s Inflation Claims Clash With Voters’ Cost-of-Living Reality
Sanofi to Acquire Dynavax in $2.2 Billion Deal to Strengthen Vaccine Portfolio
Trump Slams Super Bowl Halftime Show Featuring Bad Bunny
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
Trump Administration Appeals Court Order to Release Hudson Tunnel Project Funding
Netanyahu to Meet Trump in Washington as Iran Nuclear Talks Intensify
Antonio José Seguro Poised for Landslide Win in Portugal Presidential Runoff 



